News

February 15, 2017 - Dr. Mauseth and Robert Kircher traveled to to the Advanced Technologies and Treatments for Diabetes Conference in Paris, France. They presented a poster entitled "Uncertainty Analysis of Insulin Doses from Bolus Calculators".
November 10, 2016 - Robert Kircher and Don Matheson traveled to Bethesda Maryland to attend the 16th annual Diabetes Technology Meeting and present a poster entitled "Nocturnal Blood Glucose Control by Fuzzy Logic (FL) Dosing Algorithm".
July 8, 2016 - Dr. Mauseth, Robert Kircher and Don Matheson traveled to Bethesda Maryland to participate in the 4th Annual Artificial Pancreas Workshop sponsored by the NIH entitled Testing and Adoption of Current and Emerging Technologies. A poster was presented updating the status of Dose Safety. Robert was on a panel discussing Interoperability, Data Management, and Cybersecurity and Richard on a panel discussing "What Is Needed to Facilitate the Development of a Viable Commercial Platform and to Deliver Artificial Pancreas Systems to People with Type 1 Diabetes (T1D) in the Near, Medium, and Long Term".
June 8, 2016 - While attending the American Diabetes Association Conference in New Orleans Dr. Mauseth presented the Dose Safety status report at the JDRF/NIH Closed-Loop Research Meeting on June 12th.
June 4, 2016 - Dr. Mauseth and Robert Kircher traveled to to the America Diabetes Association 76th conference in New Orleans. They will present a poster entitled ”Safe Automated Insulin Delivery During Daily Living Conditions”.
January 31, 2016 - Dose Safety released a CEO Newsletter from Dr. Mauseth.
January 30, 2016 - Dr. Mauseth and Robert Kircher traveled to to the Advanced Technologies and Treatments for Diabetes conference in Milan, Italy. Dr. Mauseth will make a presentation entitled “Ad-lib living studies give way to Hybrid / Fully Automated Closed Loop Artificial Pancreas”. Mr. Kircher will make a presentation entitled “Algorithmic Changes Reduce Compute Time by 46% for AP Controller Software”. He will also display a poster entitled “Automated Insulin Delivery “’In The Wild’”.
Sept 15, 2015 - The results of two human trials using the Dose Safety Controller were published in the Journal of Diabetes Science and Technology, Sept 2015 in an original article entitled “Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System’s Fuzzy Logic Controller
June 4, 2015 - Dose Safety Algorithm the First Fully Automated Artificial Pancreas
Dr. Richard Mauseth announced today the availability of the first fully automated insulin pump controller. Dr. Mauseth says of the Dose Safety controller that “you turn our system on and forget about it. It’s the only hands free artificial pancreas dosing algorithm, and the software runs on any smartphone or programmable chip in an insulin pump.”
February 18 2015 - Dr. Mauseth and Robert Kircher traveled to the Advanced Technologies and Treatments for Diabetes conference in Paris. Dr. Mauseth presented a poster entitled "Efficacy and Computational Efficiency of the Dose Safety Hypoglycemia Prevention Module (HPM)".
December 6, 2014 - Dose Safety was awarded a 2-year grant from the National Institutes of Health. Research will take place at the Beneroya Research Institute (BRI) in Seattle and in the participant's home and workplace to evaluate the ability of the Dose Safety fuzzy logic controller to reverse hypoglycemic unawareness. Twenty participants are planned.
November 20, 2014 - Robert Kircher attended the Fall 2014 DiabetesMine D-Data ExChange in PaloAlto CA and presented Artificial Pancreas Case Studies: "How Dose Safety Invented Its AP Control Algorithm".
November 6, 2014 - The Dose Safety team attended the Diabetes Technology Meeting in Bethesda MD. Two posters were presented, Improved Prediction Accuracy and Dynamic Bayesian Network (DBN) Glucoregulatory System Model and Smart Low Glucose Suspend Capabilities of the Dose Safety Fuzzy Logic Dosing Controller.
June 15 2014 - The Dose Safety team traveled to San Francisco for the 74rd American Diabetes Association (ADA) meeting. Bob Kircher (VP of Engr & Reg. Affairs) presented "The Last Mile - Bridging from Academia to Industry" at a meeting hosted jointly by JDRF and the NIH.
April 5 2014 - Dr. Mauseth presented "Developing an Artificial Pancreas, The History & Future of Dose Safety" at the 2014 American Diabetes Association Expo in Seattle. Photos from the event are here.
February 5 2014 - Dr. Mauseth and Bob Kircher traveled to the Advanced Technologies and Treatments for Diabetes conference in Vienna. Dr. Mauseth presented a poster entitled "Testing a Fuzzy Logic Artificial Pancreas Controller". Bob presented a posted entitled "Procedure for Creating the Baseline Dynamic Bayesian Network (DBN) Glucoregulatory System Statistical Model for Artificial Pancreas Safety Monitor".
October 23, 2013 - The King County Medical Society published an article on the history and development of the artificial pancreas, authored by Dana VanBuecken, the Beneroya Research Institute nurse practitioner who coordinates the trials Dose Safety is conducting. The progress of Dose Safety and other advances toward an artificial pancreas are described.
October 1, 2013 - The US Patent Office issued patent No. 8548544 “System, Method and Article for Controlling the Dispensing of Insulin” which covers our fuzzy logic insulin pump controller. We have a second patent pending.
August 20, 2013 - Benaroya Research Institute, with whom we are partnered for clinical trials, has posted a story on one of the trial participants Annie Shultz. In addition to Annie's comments a concise summary of an artificial pancreas and a link to the local TV station that carried the story is provided.
July 5, 2013 - A peer-reviewed paper describing results of the clinical trials of the Dose Safety controller will be published in the August issue of the journal Diabetes Technology & Therapeutics under the title Use of a “Fuzzy Logic” Controller in a Closed-Loop Artificial Pancreas. It was jointly authored by members of Dose Safety, Benaroya Research Institute and the University of Washington.
June 22, 2013 - The Dose Safety team traveled to Chicago for the 73rd annual American Diabetes Association (ADA) meeting. A poster was presented by Bob Kircher entitled Dynamic Bayesian Network (DBN) Model for Blood Glucose Prediction.
April 2 2013 - Dose Safety received FDA approval to revise fuzzy logic parameters and begin use of Dexcom G4 sensors in human trials. This will allow the request for Institutional review board (IRB) review of planned human studies at the Benaroya Research Institute.
March 21, 2013 - An article was published in the the JDRF on-line magazine Countdown about the history and goals of Dose Safety.
February 27 2013 - Dr. Mauseth and Bob Kircher traveled to the Advanced Technologies and Treatments for Diabetes conference in Paris. Dr. Mauseth presented a paper entitled “Pilot Study using Fuzzy Logic Controller for an Artificial Pancreas”.
October 1-5 2012 - The Dose Safety team presented posters at the EASD conference in Berlin entitled “Clinical Test of Fuzzy Logic Controller (FLC) in a Closed Loop Artificial Pancreas” and “Proposal for Artificial Pancreas device system-level mode logic”.
September 2012 - The FDA approved the investigational device exemption (IDE) for the JDRF funded studies. Human trials will begin in late October 2012.
July 2012 - Dose Safety was awarded a grant from the Juvenile Diabetes Research Foundation (JDRF). Research conducted at the Beneroya Research Institute (BRI) in Seattle will evaluate the safety and reliability of the Dose Safety fuzzy logic controller during periods of exercise and following a high carbohydrate, high fat meal. Up to 20 subjects will be evaluated.
June 2012 - The Dose Safety team presented a poster at the 2012 ADA conference in Philadelphia entitled “Use of Fuzzy Logic Controller (FLC) in a Closed Loop Artificial Pancreas”.